Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2024/09/20 23:03 EDT
Last
 236.58
-1.1 (-0.46%)
Day High 
237.94 
Prev. Close
237.68 
1-M High
243.98 
Volume 
1.35M 
Bid
217.49
Ask
239.39
Day Low
231.225 
Open
235.29 
1-M Low
180.31 
Market Cap 
16.67B 
Currency USD 
P/E 42.98 
%Yield -- 
10-SMA 229.57 
20-SMA 214.36 
50-SMA 202.2 
52-W High 243.98 
52-W Low 125.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
5.53/3.76
Enterprise Value
18.03B
Balance Sheet
Book Value Per Share
14.24
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.70B
Operating Revenue Per Share
22.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDTMedtronic plc89.34-0.13-0.15%30.12PE
TNONTenon Medical Inc5.44+0.41+8.15%-- 
PACBPacific Biosciences of California1.825-0.215-10.54%-- 
EWEdwards Lifesciences Corp66.83-0.43-0.64%26.48PE
SENSSenseonics Holdings0.3601-0.0074-2.01%-- 
Quotes are at least 15-min delayed:2024/09/20 23:03 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.